iShares U.S. Healthcare ETF (IYH)
|Ex-Dividend Date||Mar 24, 2022|
|Day's Range||275.64 - 280.18|
|Inception Date||Jun 12, 2000|
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
Top 10 Holdings53.57% of assets
|Johnson & Johnson||JNJ||9.20%|
|Eli Lilly and Company||LLY||5.17%|
|Merck & Co.||MRK||4.55%|
|Thermo Fisher Scientific||TMO||4.13%|
|Bristol-Myers Squibb Company||BMY||3.29%|
|Mar 24, 2022||$0.68729||Mar 30, 2022|
|Dec 13, 2021||$0.77933||Dec 17, 2021|
|Sep 24, 2021||$0.849||Sep 30, 2021|
|Jun 10, 2021||$0.53004||Jun 16, 2021|
|Mar 25, 2021||$0.66063||Mar 31, 2021|
|Dec 14, 2020||$0.75704||Dec 18, 2020|
Sector ETF report for IYH
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfolio.
UnitedHealth reported better-than-expected first-quarter 2020 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance.
Investors are seeking refuge in healthcare stocks as inflation and rates rise
Let's take a look at some healthcare ETFs that are regaining popularity among investors as COVID-19 cases rise in China and market uncertainties increase.
Let's take a look at some healthcare ETFs that are regaining popularity among investors as COVID-19 cases rise in China.
Both the healthcare and banking industries should do well this year.
Take a look at some top-ranked ETFs that might help strengthen your portfolio and rake in some good returns.
Amid the market uncertainty, we have highlighted some ETF areas that can be good investment options for market participants to combat the September chaos.
It could be enough to make you a millionaire.
And they can instantly diversify your holdings.
Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate...
UnitedHealth agreed to buy Change Healthcare for $7.84 billion in cash.
The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.
We have highlighted one ETF and one stock from the four sectors that could make great plays as the earnings season unfolds.
The halt in stimulus talks has made investors jittery, resulting in a flight to defensive sectors like utilities, real estate, healthcare and consumer staples.